QR-kod

Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial

Simple summaryStereotactic body radiotherapy (SBRT) of 35–36.25 Gy in five fractions with the CyberKnife System yields excellent control with low toxicity in low–intermediate-risk prostate cancer patients. We found no differences in biochemical control and overall survival in relation to dose. There...

Full beskrivning

Sparad:
Huvudupphov: Valentina Borzillo, Esmeralda Scipilliti, Donato Pezzulla, Marcello Serra, Gianluca Ametrano, Giuseppe Quarto, Sisto Perdonà, Sabrina Rossetti, Sandro Pignata, Anna Crispo, Piergiacomo Di Gennaro, Valentina D’Alesio, Cecilia Arrichiello, Francesca Buonanno, Simona Mercogliano, Antonio Russo, Antonio Tufano, Rossella Di Franco, Paolo Muto
Materialtyp: Artigo
Språk:Inglês
Utgiven: Frontiers Media S.A. 2023-11-01
Serie:Frontiers in Oncology
Ämnen:
clinical outcome
toxicity
low-and intermediate-risk
radiotherapy
prostate cancer
stereotactic body radiation
Länkar:https://www.frontiersin.org/articles/10.3389/fonc.2023.1270498/full
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk